another article in the WSJ about M&A activity heat

another article in the WSJ about M&A activity heating up in the biotech space. The demand for good drugs is very high - but they mention only after clinical results showing efficacy, safety, etc. - i guess that would be a legit phase II or something along those lines - still down the line for us.

what does that mean for us? like John Fogerty said: "Put Me In Coach!". Time for us to get off the bench and get into the game. And to be clear, "the game" is selling our drug - or at least, creating data that shows that our drug works - such that we can get bought, partnered with, etc. we've been collecting splinters in our ass for years while others are racing for the shiny prizes. and hence the all-time low SP and my retirement fund down 90% over the past couple years - ouch.

Bottom line - Let's get a CEO ASAP who is laser focused on deal making. sure, i hope to get some money from Amarex - but i'd take less now, as our real enemy here is time - and missing our window. While i certainly think The window is still open - it won't be forever. Especially with AI, deep-pocketed competitors, etc. -Let's get in the game for god's sake!

Hope everyone has a good weekend!